LogicBio Therapeutics, Inc. Accrued Liabilities, Current
LogicBio Therapeutics, Inc. had Accrued Liabilities, Current of $2.32 million as of 2022-09-30, per its 10-Q filed 2022-11-14.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2022-11-14
- 2022-09-30: Accrued Liabilities, Current $2.32M.
- 2022-06-30: Accrued Liabilities, Current $1.79M.
- 2022-03-31: Accrued Liabilities, Current $1.76M.
- 2021-12-31: Accrued Liabilities, Current $3.70M.
| Period end | Accrued Liabilities, Current | Accrued Liabilities, Current as first filed |
|---|---|---|
| 2022-09-30 | $2.32M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $1.79M 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $1.76M 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $3.70M 10-Q · filed 2022-11-14 | |
| 2021-09-30 | $3.47M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $3.61M 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $3.13M 10-Q · filed 2021-05-10 | |
| 2020-12-31 | $2.70M 10-K · filed 2022-03-04 | |
| 2020-09-30 | $2.18M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $2.21M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $1.93M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $2.44M 10-K · filed 2021-03-15 | $2.94M 10-K · filed 2020-03-16 |
| 2019-09-30 | $2.18M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $2.96M 10-Q · filed 2019-08-13 | |
| 2019-03-31 | $2.35M 10-Q · filed 2019-05-14 | |
| 2018-12-31 | $1.52M 10-K · filed 2020-03-16 | |
| 2018-09-30 | $1.57M 10-Q · filed 2018-12-03 | |
| 2017-12-31 | $599.00K 10-K · filed 2019-04-01 |